# LiveWire Group, Inc.: financial statements, quarterly

LVWR · NYSE · CIK 1898795 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lvwr.md) · [Financials](/companies/lvwr/financials.md) · [Filings](/companies/lvwr/filings.md) · [Insiders](/companies/lvwr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lvwr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.1](/filings/0001898795-24-000307.md) | [15.1 d](/filings/0001898795-26-000028.md) | [5.0](/filings/0001898795-25-000105.md) | [6.4](/filings/0001898795-25-000162.md) | [4.4](/filings/0001898795-25-000197.md) | [10.8 d](/filings/0001898795-26-000028.md) | [2.7](/filings/0001898795-26-000048.md) | [5.9](/filings/0001898795-26-000085.md) | [5.7](/filings/0001898795-25-000197.md) | [11.4 d](/filings/0001898795-26-000028.md) | [5.1](/filings/0001898795-26-000048.md) | [9.1](/filings/0001898795-26-000085.md) |
| Cost of revenue | $m | [7.1](/filings/0001898795-24-000307.md) | [20.3 d](/filings/0001898795-26-000028.md) | [9.1](/filings/0001898795-25-000105.md) | [8.2](/filings/0001898795-25-000162.md) | [6.0](/filings/0001898795-25-000197.md) | [16.1 d](/filings/0001898795-26-000028.md) | [4.9](/filings/0001898795-26-000048.md) | [5.3](/filings/0001898795-26-000085.md) | [8.6](/filings/0001898795-25-000197.md) | [11.3 d](/filings/0001898795-26-000028.md) | [5.7](/filings/0001898795-26-000048.md) | [9.2](/filings/0001898795-26-000085.md) |
| Selling, general and administrative | $m | [26.4](/filings/0001898795-24-000307.md) | [28.6 d](/filings/0001898795-26-000028.md) | [26.3](/filings/0001898795-25-000105.md) | [26.4](/filings/0001898795-25-000162.md) | [25.0](/filings/0001898795-25-000197.md) | [19.9 d](/filings/0001898795-26-000028.md) | [18.5](/filings/0001898795-26-000048.md) | [18.8](/filings/0001898795-26-000085.md) | [15.9](/filings/0001898795-25-000197.md) | [17.8 d](/filings/0001898795-26-000028.md) | [17.1](/filings/0001898795-26-000048.md) | [18.0](/filings/0001898795-26-000085.md) |
| Operating income | $m | [(25.3)](/filings/0001898795-24-000307.md) | [(33.8) d](/filings/0001898795-26-000028.md) | [(30.4)](/filings/0001898795-25-000105.md) | [(28.2)](/filings/0001898795-25-000162.md) | [(26.5)](/filings/0001898795-25-000197.md) | [(25.2) d](/filings/0001898795-26-000028.md) | [(20.7)](/filings/0001898795-26-000048.md) | [(18.3)](/filings/0001898795-26-000085.md) | [(18.8)](/filings/0001898795-25-000197.md) | [(17.7) d](/filings/0001898795-26-000028.md) | [(17.7)](/filings/0001898795-26-000048.md) | [(18.0)](/filings/0001898795-26-000085.md) |
| Income tax | $m | [(0.0)](/filings/0001898795-24-000307.md) | [0.0 d](/filings/0001898795-26-000028.md) | [(0.0)](/filings/0001898795-25-000105.md) | [0.0](/filings/0001898795-25-000162.md) | [0.0](/filings/0001898795-25-000197.md) | [0.0 d](/filings/0001898795-26-000028.md) | [0.0](/filings/0001898795-26-000048.md) | [(0.0)](/filings/0001898795-26-000085.md) | [0.1](/filings/0001898795-25-000197.md) | [0.1 d](/filings/0001898795-26-000028.md) | [0.0](/filings/0001898795-26-000048.md) | [0.1](/filings/0001898795-26-000085.md) |
| Net income | $m | [(14.6)](/filings/0001898795-24-000307.md) | [(33.1) d](/filings/0001898795-26-000028.md) | [(23.6)](/filings/0001898795-25-000197.md) | [(24.8)](/filings/0001898795-25-000197.md) | [(22.7)](/filings/0001898795-25-000197.md) | [(22.8) d](/filings/0001898795-26-000028.md) | [(19.3)](/filings/0001898795-26-000085.md) | [(18.8)](/filings/0001898795-26-000085.md) | [(19.4)](/filings/0001898795-25-000197.md) | [(17.6) d](/filings/0001898795-26-000028.md) | [(18.1)](/filings/0001898795-26-000085.md) | [(18.2)](/filings/0001898795-26-000085.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0001898795-24-000307.md) | not reported | [(0.12)](/filings/0001898795-25-000105.md) | [(0.12)](/filings/0001898795-25-000162.md) | [(0.11)](/filings/0001898795-25-000197.md) | not reported | [(0.09)](/filings/0001898795-26-000048.md) | [(0.09)](/filings/0001898795-26-000085.md) | [(0.10)](/filings/0001898795-25-000197.md) | not reported | [(0.09)](/filings/0001898795-26-000048.md) | [(0.09)](/filings/0001898795-26-000085.md) |
| Basic EPS | $ per share | [(0.07)](/filings/0001898795-24-000307.md) | not reported | [(0.12)](/filings/0001898795-25-000105.md) | [(0.12)](/filings/0001898795-25-000162.md) | [(0.11)](/filings/0001898795-25-000197.md) | not reported | [(0.09)](/filings/0001898795-26-000048.md) | [(0.09)](/filings/0001898795-26-000085.md) | [(0.10)](/filings/0001898795-25-000197.md) | not reported | [(0.09)](/filings/0001898795-26-000048.md) | [(0.09)](/filings/0001898795-26-000085.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [200](/filings/0001898795-23-000169.md) | [168](/filings/0001898795-25-000055.md) | [141](/filings/0001898795-24-000131.md) | [113](/filings/0001898795-24-000263.md) | [88.4](/filings/0001898795-24-000307.md) | [64.4](/filings/0001898795-26-000028.md) | [46.2](/filings/0001898795-25-000105.md) | [29.3](/filings/0001898795-25-000162.md) | [16.3](/filings/0001898795-25-000197.md) | [82.8](/filings/0001898795-26-000085.md) | [67.5](/filings/0001898795-26-000048.md) | [52.9](/filings/0001898795-26-000085.md) |
| Current assets | $m | [240](/filings/0001898795-23-000169.md) | [211](/filings/0001898795-25-000055.md) | [182](/filings/0001898795-24-000131.md) | [151](/filings/0001898795-24-000263.md) | [127](/filings/0001898795-24-000307.md) | [98.4](/filings/0001898795-26-000028.md) | [81.6](/filings/0001898795-25-000105.md) | [64.9](/filings/0001898795-25-000162.md) | [46.3](/filings/0001898795-25-000197.md) | [105](/filings/0001898795-26-000085.md) | [87.8](/filings/0001898795-26-000048.md) | [75.7](/filings/0001898795-26-000085.md) |
| Total assets | $m | [296](/filings/0001898795-23-000169.md) | [266](/filings/0001898795-26-000028.md) | [237](/filings/0001898795-24-000131.md) | [205](/filings/0001898795-24-000263.md) | [178](/filings/0001898795-24-000307.md) | [148](/filings/0001898795-26-000028.md) | [128](/filings/0001898795-25-000105.md) | [110](/filings/0001898795-25-000162.md) | [89.2](/filings/0001898795-25-000197.md) | [146](/filings/0001898795-26-000085.md) | [128](/filings/0001898795-26-000048.md) | [118](/filings/0001898795-26-000085.md) |
| Current liabilities | $m | [45.4](/filings/0001898795-23-000169.md) | [46.3](/filings/0001898795-25-000055.md) | [44.1](/filings/0001898795-24-000131.md) | [38.8](/filings/0001898795-24-000263.md) | [35.9](/filings/0001898795-24-000307.md) | [29.9](/filings/0001898795-26-000028.md) | [28.6](/filings/0001898795-25-000105.md) | [27.2](/filings/0001898795-25-000162.md) | [24.1](/filings/0001898795-25-000197.md) | [22.7](/filings/0001898795-26-000085.md) | [20.5](/filings/0001898795-26-000048.md) | [18.2](/filings/0001898795-26-000085.md) |
| Total liabilities | $m | [57.4](/filings/0001898795-23-000169.md) | [60.3](/filings/0001898795-25-000055.md) | [53.3](/filings/0001898795-24-000131.md) | [45.9](/filings/0001898795-24-000263.md) | [40.6](/filings/0001898795-24-000307.md) | [32.8](/filings/0001898795-26-000028.md) | [31.1](/filings/0001898795-25-000105.md) | [30.1](/filings/0001898795-25-000162.md) | [27.4](/filings/0001898795-25-000197.md) | [100](/filings/0001898795-26-000085.md) | [99.3](/filings/0001898795-26-000048.md) | [106](/filings/0001898795-26-000085.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001898795-26-000028.md) | not reported | not reported | not reported | [74.2](/filings/0001898795-26-000085.md) | [74.2](/filings/0001898795-26-000048.md) | [76.8](/filings/0001898795-26-000085.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001898795-26-000028.md) | not reported | not reported | not reported | [0.8](/filings/0001898795-26-000085.md) | [0.0](/filings/0001898795-26-000048.md) | [0.0](/filings/0001898795-26-000085.md) |
| Shareholders' equity | $m | [239](/filings/0001898795-24-000307.md) | [206](/filings/0001898795-26-000028.md) | [184](/filings/0001898795-25-000197.md) | [159](/filings/0001898795-25-000197.md) | [138](/filings/0001898795-25-000197.md) | [115](/filings/0001898795-26-000085.md) | [97.2](/filings/0001898795-26-000085.md) | [79.7](/filings/0001898795-26-000085.md) | [61.8](/filings/0001898795-25-000197.md) | [46.0](/filings/0001898795-26-000085.md) | [28.3](/filings/0001898795-26-000085.md) | [11.9](/filings/0001898795-26-000085.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(14.7) d](/filings/0001898795-24-000307.md) | [(27.6) d](/filings/0001898795-26-000028.md) | [(22.9)](/filings/0001898795-25-000105.md) | [(26.0) d](/filings/0001898795-25-000162.md) | [(23.1) d](/filings/0001898795-25-000197.md) | [(21.9) d](/filings/0001898795-26-000028.md) | [(17.5)](/filings/0001898795-26-000048.md) | [(14.9) d](/filings/0001898795-26-000085.md) | [(13.3) d](/filings/0001898795-25-000197.md) | [(7.9) d](/filings/0001898795-26-000028.md) | [(13.0)](/filings/0001898795-26-000048.md) | [(13.4) d](/filings/0001898795-26-000085.md) |
| Capital expenditure | $m | [2.8 d](/filings/0001898795-24-000307.md) | [2.5 d](/filings/0001898795-26-000028.md) | [3.2](/filings/0001898795-25-000105.md) | [1.8 d](/filings/0001898795-25-000162.md) | [1.6 d](/filings/0001898795-25-000197.md) | [1.4 d](/filings/0001898795-26-000028.md) | [0.6](/filings/0001898795-26-000048.md) | [1.4 d](/filings/0001898795-26-000085.md) | [0.7 d](/filings/0001898795-25-000197.md) | [1.0 d](/filings/0001898795-26-000028.md) | [0.7](/filings/0001898795-26-000048.md) | [0.8 d](/filings/0001898795-26-000085.md) |
| Share repurchases | $m | [0.0 d](/filings/0001898795-24-000307.md) | [2.0 d](/filings/0001898795-26-000028.md) | [0.7](/filings/0001898795-25-000105.md) | [0.2 d](/filings/0001898795-25-000162.md) | [0.0 d](/filings/0001898795-25-000197.md) | [0.5 d](/filings/0001898795-26-000028.md) | [0.3](/filings/0001898795-26-000048.md) | [0.5 d](/filings/0001898795-26-000085.md) | [0.0 d](/filings/0001898795-25-000197.md) | [0.3 d](/filings/0001898795-26-000028.md) | [0.8](/filings/0001898795-26-000048.md) | [0.1 d](/filings/0001898795-26-000085.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-25) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [161](/filings/0001898795-23-000169.md) | [202](/filings/0001898795-24-000131.md) | [202](/filings/0001898795-24-000263.md) | [203](/filings/0001898795-24-000307.md) | [203](/filings/0001898795-25-000105.md) | [203](/filings/0001898795-25-000162.md) | [203](/filings/0001898795-25-000197.md) | [203](/filings/0001898795-26-000048.md) | [204](/filings/0001898795-26-000085.md) | [204](/filings/0001898795-25-000197.md) | [204](/filings/0001898795-26-000048.md) | [205](/filings/0001898795-26-000085.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 205,412,457 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001898795-26-000085.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.